India's Pharmaceutical Exports

Country Profile

Panama

Panama is an emerging destination for Indian pharmaceutical exports — $26.8M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $599K. The compound annual growth rate since FY2015 stands at 11.9%.

🇵🇦 $26.8M · 3.5× growth since FY2015 · 11.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$26.8M
Exports FY2025–26 DGCIS
3.5×
Growth FY2015→2026
11.9%
CAGR FY2015→2026
87%
Medicines Share
5
Product Categories Supplied
Panama is an emerging destination for Indian pharmaceutical exports — $26.8M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $599K. The compound annual growth rate since FY2015 stands at 11.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $23.4M (87.5%) Medicine Ingredients $1.11M (4.1%) Traditional & Herbal $1.06M (4.0%) Vaccines $599K (2.2%) Surgical & Hospital Supplies $587K (2.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Panama in the RBI overseas direct investment dataset (2011–2026).